Stephan Schindler
Chairman bij EVOLVA HOLDING SA
Profiel
Stephan Schindler is currently the Chairman at Evolva Holding SA, Director at Bachem Americas, Inc., Secretary & Director at Bachem (U.K.) Ltd., Director at University Children's Hospital Basel, Director at Arcondis AG, and Member-Supervisory Board at Bachem AG.
Previously, he served as the Director at Columna Collective Foundation Client Invest from 2017 to 2021 and as the Chief Financial Officer at Bachem Holding AG from 2009 to 2021.
He also held positions as the Head-Finance & Control at DSM Nutritional Products AG and Head-Information Center at Patria Insurances.
Actieve functies van Stephan Schindler
Bedrijven | Functie | Begin |
---|---|---|
EVOLVA HOLDING SA | Chairman | 18-04-2023 |
Bachem Americas, Inc.
Bachem Americas, Inc. Pharmaceuticals: MajorHealth Technology Bachem Americas, Inc. engages in development of pharmaceutical ingredients through solid-phase peptide synthesis. The company is headquartered in Torrance, CA. | Director/Board Member | - |
Arcondis AG
Arcondis AG Miscellaneous Commercial ServicesCommercial Services Arcondis AG is the largest consulting Swiss company in Switzerland that exclusively specializes in the life sciences industry. The private company is based in Reinach, Switzerland. The company provides consulting services to clients in the healthcare and life science industries, with a focus on quality and regulatory aspects. Arcondis has expertise in compliance, business processes, information technology, and digital transformation and engagement. | Director/Board Member | 01-01-2016 |
Bachem (U.K.) Ltd.
Bachem (U.K.) Ltd. Pharmaceuticals: MajorHealth Technology Part of Bachem Holding AG, Bachem (U.K.) Ltd. is a leading, British innovation-driven company specializing in the development and manufacture of peptides and oligonucleotides. The private company is based in St. Helens, UK. The company's dedicated and experienced project leaders ensure the development and manufacturing of products through close collaboration with the project team. Whatever the needs for non-GMP products, Bachem can prepare compounds according to specifications in any scale. Founded in 1986, the company provides solutions for today and innovation for tomorrow. | Director/Board Member | 26-02-2015 |
Bachem AG
Bachem AG Pharmaceuticals: MajorHealth Technology Bachem AG engages in the sale and distribution of active pharmaceutical ingredients and research grade products. The firm’s products include peptides and complex organic molecules, as well as new chemical entities and generic active pharmaceutical ingredients. It also focuses on peptide research and development, including custom peptide synthesis. The company was founded by Peter Grogg in 1971 and is headquartered in Bubendorf, Switzerland. | Director/Board Member | - |
University Children's Hospital Basel
University Children's Hospital Basel Hospital/Nursing ManagementHealth Services University Children's Hospital Basel provides a large-scale biomedical database and research resource called UK Biobank. The private company is based in Basel, Switzerland. The database contains in-depth genetic and health information from half a million UK participants, which is regularly augmented with additional data. Approved researchers and scientists can access the database to undertake vital research into the most common and life-threatening diseases. UK Biobank has enabled several scientific discoveries that improve human health. | Director/Board Member | 01-01-2021 |
Eerdere bekende functies van Stephan Schindler
Bedrijven | Functie | Einde |
---|---|---|
BACHEM HOLDING AG | Director of Finance/CFO | 01-02-2021 |
Columna Collective Foundation Client Invest | Director/Board Member | 01-01-2021 |
DSM Nutritional Products AG
DSM Nutritional Products AG Chemicals: SpecialtyProcess Industries Part of DSM-Firmenich AG, DSM Nutritional Products AG is a Swiss purpose-led science-based company in nutrition, health, and bioscience. The private company is based in Kaiseraugst, Switzerland. The company provides solutions for animal nutrition, human nutrition & care, food & beverage, and materials. DSM's climate change agenda focuses on reducing their own carbon footprint, enabling the low-carbon economy with their solutions, and advocating climate action. The CEO of the company is Dimitri de Vreeze. | Director of Finance/CFO | 01-01-2009 |
░░░░░░ ░░░░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 2 |
---|---|
BACHEM HOLDING AG | Health Technology |
EVOLVA HOLDING SA | Consumer Non-Durables |
Bedrijven in privébezit | 8 |
---|---|
DSM Nutritional Products AG
DSM Nutritional Products AG Chemicals: SpecialtyProcess Industries Part of DSM-Firmenich AG, DSM Nutritional Products AG is a Swiss purpose-led science-based company in nutrition, health, and bioscience. The private company is based in Kaiseraugst, Switzerland. The company provides solutions for animal nutrition, human nutrition & care, food & beverage, and materials. DSM's climate change agenda focuses on reducing their own carbon footprint, enabling the low-carbon economy with their solutions, and advocating climate action. The CEO of the company is Dimitri de Vreeze. | Process Industries |
Bachem Americas, Inc.
Bachem Americas, Inc. Pharmaceuticals: MajorHealth Technology Bachem Americas, Inc. engages in development of pharmaceutical ingredients through solid-phase peptide synthesis. The company is headquartered in Torrance, CA. | Health Technology |
Bachem AG
Bachem AG Pharmaceuticals: MajorHealth Technology Bachem AG engages in the sale and distribution of active pharmaceutical ingredients and research grade products. The firm’s products include peptides and complex organic molecules, as well as new chemical entities and generic active pharmaceutical ingredients. It also focuses on peptide research and development, including custom peptide synthesis. The company was founded by Peter Grogg in 1971 and is headquartered in Bubendorf, Switzerland. | Health Technology |
Bachem (U.K.) Ltd.
Bachem (U.K.) Ltd. Pharmaceuticals: MajorHealth Technology Part of Bachem Holding AG, Bachem (U.K.) Ltd. is a leading, British innovation-driven company specializing in the development and manufacture of peptides and oligonucleotides. The private company is based in St. Helens, UK. The company's dedicated and experienced project leaders ensure the development and manufacturing of products through close collaboration with the project team. Whatever the needs for non-GMP products, Bachem can prepare compounds according to specifications in any scale. Founded in 1986, the company provides solutions for today and innovation for tomorrow. | Health Technology |
University Children's Hospital Basel
University Children's Hospital Basel Hospital/Nursing ManagementHealth Services University Children's Hospital Basel provides a large-scale biomedical database and research resource called UK Biobank. The private company is based in Basel, Switzerland. The database contains in-depth genetic and health information from half a million UK participants, which is regularly augmented with additional data. Approved researchers and scientists can access the database to undertake vital research into the most common and life-threatening diseases. UK Biobank has enabled several scientific discoveries that improve human health. | Health Services |
Arcondis AG
Arcondis AG Miscellaneous Commercial ServicesCommercial Services Arcondis AG is the largest consulting Swiss company in Switzerland that exclusively specializes in the life sciences industry. The private company is based in Reinach, Switzerland. The company provides consulting services to clients in the healthcare and life science industries, with a focus on quality and regulatory aspects. Arcondis has expertise in compliance, business processes, information technology, and digital transformation and engagement. | Commercial Services |
Patria Insurances | |
Columna Collective Foundation Client Invest |